Q3 FY26 results: Revenue up around 72% YoY, swings to profit of Rs 69.19 cr
TRUALT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.7 pts less than Nifty Microcap 250 and 5.9 pts less than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TruAlt Bioenergy reported Q3 FY26 consolidated revenue of Rs 713.24 cr, up around 72% YoY from Rs 415.11 cr. PAT swung to Rs 69.19 cr from a loss of Rs 37.94 cr. 9M FY26 revenue rose 13% to Rs 1,131.99 cr with PAT of Rs 35.92 cr. Recently listed via IPO that raised Rs 750 cr, and signed JVs with Sumitomo for CBG and Honeywell for SAF production. New Company Secretary appointed.
Strong Q3 turnaround on seasonal peak and resumed capacity. Positive catalysts from IPO, Sumitomo JV, and Honeywell SAF deal.